Noninvasive Bioluminescent Imaging Demonstrates Long‐Term Multilineage Engraftment of Ex Vivo‐Expanded CD34‐Selected Umbilical Cord Blood Cells

The use of umbilical cord blood (UCB) grafts for hematopoietic stem cell transplantation (HSCT) is a promising technique that permits a degree of human leukocyte antigen mismatch between the graft and the host without the concomitant higher rate of graft‐versus‐host disease that would be observed between an adult marrow graft and a mismatched host. A disadvantage to the use of UCB for HSCT is that immune reconstitution may be significantly delayed because of the low stem cell dose available in the graft. Ex vivo expansion of UCB CD34 cells would provide a greater number of stem cells; however, there are persistent concerns that ex vivo‐expanded CD34 cells may lose pluripotency and the ability to contribute meaningfully to long‐term engraftment. To address this issue, we transduced CD34‐selected UCB cells with a lentiviral construct expressing luciferase, and determined homing and engraftment patterns in vivo by noninvasive bioluminescent imaging in sublethally irradiated NOD/SCID/IL‐2Rγ−/− (NSG) mice. Graft contribution to multilineage commitment was also confirmed by analysis of primary and secondary transplants by flow cytometry and immunohistochemistry. Our results demonstrate that, other than a mild delay at the onset of engraftment, there were no significant differences in lineage repopulation or in long‐term or secondary engraftment between culture‐expanded and unexpanded UCB CD34‐selected cells. The results suggest that multipotent stem cells can be expanded ex vivo and can contribute meaningfully to long‐term hematopoietic engraftment. STEM CELLS 2009;27:1932–1940

[1]  David W. Rowe,et al.  Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche , 2009, Nature.

[2]  K. Pollok,et al.  Identification of parameters required for efficient lentiviral vector transduction and engraftment of human cord blood CD34(+) NOD/SCID-repopulating cells. , 2008, Experimental hematology.

[3]  R. Woodland,et al.  Expanded CD34+ Human Umbilical Cord Blood Cells Generate Multiple Lymphohematopoietic Lineages in NOD-scid IL2rγ null Mice , 2008, Experimental biology and medicine.

[4]  A. Nagler,et al.  Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial , 2008, Bone Marrow Transplantation.

[5]  H. Lodish,et al.  Angiopoietin-like 5 and IGFBP2 stimulate ex vivo expansion of human cord blood hematopoietic stem cells as assayed by NOD/SCID transplantation. , 2008, Blood.

[6]  R. Woodland,et al.  A new Hu-PBL model for the study of human islet alloreactivity based on NOD-scid mice bearing a targeted mutation in the IL-2 receptor gamma chain gene. , 2008, Clinical immunology.

[7]  Z. Lee,et al.  Bioluminescence imaging of hematopoietic stem cell repopulation in murine models. , 2008, Methods in molecular biology.

[8]  J. Wagner,et al.  Umbilical cord blood transplantation after nonmyeloablative conditioning: impact on transplantation outcomes in 110 adults with hematologic disease. , 2007, Blood.

[9]  D. Greiner,et al.  Humanized NOD/LtSz‐scid IL2 Receptor Common Gamma Chain Knockout Mice in Diabetes Research , 2007, Annals of the New York Academy of Sciences.

[10]  E. Shpall,et al.  Superior ex vivo cord blood expansion following co-culture with bone marrow-derived mesenchymal stem cells , 2006, Bone Marrow Transplantation.

[11]  H. Lodish,et al.  Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells , 2006, Nature Medicine.

[12]  K. Akashi,et al.  Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice , 2005 .

[13]  H. Lodish,et al.  Murine hematopoietic stem cells change their surface phenotype during ex vivo expansion. , 2005, Blood.

[14]  Todd E DeFor,et al.  Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. , 2005, Blood.

[15]  J. Wagner,et al.  Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. , 2004, The New England journal of medicine.

[16]  E. Shpall,et al.  Ex vivo expansion of cord blood mononuclear cells on mesenchymal stem cells. , 2004, Cytotherapy.

[17]  A. von Drygalski,et al.  Murine bone marrow cells cultured ex vivo in the presence of multiple cytokine combinations lose radioprotective and long-term engraftment potential. , 2004, Stem cells and development.

[18]  S. Chevret,et al.  Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. , 2004, Experimental hematology.

[19]  H. Lodish,et al.  Insulin-like growth factor 2 expressed in a novel fetal liver cell population is a growth factor for hematopoietic stem cells. , 2004, Blood.

[20]  J. Wagner,et al.  Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning. , 2003, Blood.

[21]  S. Gambhir,et al.  Noninvasive imaging of lentiviral-mediated reporter gene expression in living mice. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  S. Karandish,et al.  Double‐chimaerism after transplantation of two human leucocyte antigen mismatched, unrelated cord blood units , 2002, British journal of haematology.

[23]  J Wagner,et al.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. , 2002, Blood.

[24]  Chan Zeng,et al.  Transplantation of ex vivo expanded cord blood. , 2002, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[25]  E. Shpall,et al.  Ex vivo expanded cord blood cells provide rapid engraftment in fetal sheep but lack long-term engrafting potential. , 2002, Experimental hematology.

[26]  J. Wagner,et al.  Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. , 2001, The New England journal of medicine.

[27]  J. Wagner,et al.  Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. , 2001, The New England journal of medicine.

[28]  S. Chevret,et al.  Results of unrelated umbilical cord blood hematopoietic stem cell transplantation. , 2001, Reviews in clinical and experimental hematology.

[29]  J. Wagner,et al.  Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. , 2001, Blood.

[30]  J. Adamson,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC only. TRIALS , 2022 .

[31]  I McNiece,et al.  Increased expansion and differentiation of cord blood products using a two-step expansion culture. , 2000, Experimental hematology.

[32]  Highly efficient gene transfer into cord blood nonobese diabetic/severe combined immunodeficiency repopulating cells by oncoretroviral vector particles pseudotyped with the feline endogenous retrovirus (RD114) envelope protein. , 2000, Blood.

[33]  J. Segovia,et al.  Delayed Engraftment of Nonobese Diabetic/Severe Combined Immunodeficient Mice Transplanted With Ex Vivo–Expanded Human CD34+ Cord Blood Cells , 1999 .

[34]  J. Segovia,et al.  Delayed engraftment of nonobese diabetic/severe combined immunodeficient mice transplanted with ex vivo-expanded human CD34(+) cord blood cells. , 1999, Blood.

[35]  J. Adamson,et al.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.

[36]  J. Tisdale,et al.  Ex vivo expansion of genetically marked rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability. , 1998, Blood.

[37]  J. Abkowitz,et al.  The Ex Vivo Expansion of Feline Marrow Cells Leads to Increased Numbers of BFU‐E and CFU‐GM but a Loss of Reconstituting Ability , 1998, Stem cells.

[38]  C. Chastang,et al.  Outcome of cord-blood transplantation from related and unrelated donors , 1997 .

[39]  E. Fitzsimons,et al.  CD34 positive PBPC expanded ex vivo may not provide durable engraftment following myeloablative chemoradiotherapy regimens , 1997, Bone Marrow Transplantation.

[40]  C. Chastang,et al.  Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. , 1997, The New England journal of medicine.

[41]  J. Kurtzberg,et al.  Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. , 1996, The New England journal of medicine.

[42]  K. Cornetta,et al.  Ex vivo expansion of murine hematopoietic progenitor cells generates classes of expanded cells possessing different levels of bone marrow repopulating potential. , 1996, Experimental hematology.

[43]  P. Quesenberry,et al.  Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. , 1996, Blood.

[44]  P. Quesenberry,et al.  Murine marrow cells expanded in culture with IL-3, IL-6, IL-11, and SCF acquire an engraftment defect in normal hosts. , 1995, Experimental hematology.

[45]  R. Hoffman,et al.  Ex vivo expansion of CD34+ cells from purified adult human bone marrow and umbilical cord blood hematopoietic progenitor cells. , 1994, Progress in clinical and biological research.

[46]  M. Moore,et al.  Ex vivo expansion of cord blood-derived stem cells and progenitors. , 1994, Blood cells.

[47]  H. Broxmeyer,et al.  Extensive proliferative capacity of single isolated CD34 human cord blood cells in suspension culture. , 1994, Blood cells.

[48]  D. Williams Ex vivo expansion of hematopoietic stem and progenitor cells--robbing Peter to pay Paul? [editorial] , 1993 .

[49]  D. Williams,et al.  Ex vivo expansion of hematopoietic stem and progenitor cells--robbing Peter to pay Paul? , 1993, Blood.

[50]  J. Wagner,et al.  Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. , 1992, Proceedings of the National Academy of Sciences of the United States of America.